The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
U.S. Senator Jacky Rosen announced that 15 additional medications have been selected for Medicare drug pricing negotiations, ...
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the ...
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback